Title : Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis.

Pub. Date : 2004 Jul

PMID : 15608367






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The purpose of the study was to compare the prevalence of p16 and K-ras mutation in PA and CP in order to evaluate their usefulness in differential diagnosis of those diseases. Protactinium cyclin dependent kinase inhibitor 2A Homo sapiens
2 Prevalence of p16 mutations in patients with PA was 18 (78,3%) and with CP - 7 (33,3%) (p<0,01). Protactinium cyclin dependent kinase inhibitor 2A Homo sapiens